Birla Fertility & IVF (BFI), India’s third-largest in-vitro fertilisation (IVF) network and a part of the $3 billion CK Birla Group,has  announced the acquisition of 12 BabyScience IVF Clinics, marking its entry into Karnataka, Maharashtra, and Tamil Nadu. BFI will now manage 50 clinics nationwide. The acquisition is a key component of Birla Fertility & IVF's strategic expansion plan, with a continued investment of over Rs 500 crore.
 
Speaking on the occasion, Abhishek Aggrawal, Chief Business Officer, Birla Fertility & IVF, stated, "We have expanded across India, to leverage our global expertise and state-of-the-art infrastructure and deliver exceptional pregnancy rates that meet international standards. Our comprehensive range of services includes gynaecological procedures, male fertility treatments, laparoscopic procedures, genetic screening, diagnostics, and donor services." 

Dr Manjunath CS, Founder of BabyScience, said, “We are excited to join this strong national brand, so that our patients will continue to benefit from the best science in the industry, and we look forward to operational enhancements as we continue to grow in Maharashtra, Tamil Nadu, and Karnataka as part of Birla Fertility & IVF.”

In a country where 28 million couples face fertility-related challenges, and less than 1% seek assistance, Birla Fertility & IVF aims to raise awareness. With this acquisition, Birla Fertility & IVF has a combined experience of over 120,000 IVF cycles and has treated more than 230,000 patients.

Image caption- L-R Dr Manjunath CS, Founder, BabyScience and Abhishek Aggarwal, Chief Business Officer, Birla Fertility & IVF